Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Mouse Model of Multiple System Atrophy: Bench to Bedside.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics - 1 Jan 2023

Stefanova Nadia

Abstract excerpt

Multiple system atrophy (MSA) is a rare neurodegenerative disorder with unclear etiology, currently difficult and delayed diagnosis, and rapid progression, leading to disability and lethality within 6 to 9 years after symptom onset. The neuropathology of MSA classifies the disease in the group of a-synucleinopathies together with Parkinson's disease and other Lewy body disorders, but features specific...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Brain
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, Transgenic

Share to Multiple System Atrophy

Share to Oligodendroglia

Share to Translational Research, Biomedical

Source

Open in PubMed Open full text

Identifiers

PMID: 35995919
DOI: 10.1007/s13311-022-01287-8
PMCID: PMC10119356

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Mouse Model of Multiple System Atrophy: Bench to Bedside.PMID 35995919Read ↗

Age‐related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophySemantic proximity Read ↗

Mouse Model of Multiple System Atrophy α-Synuclein Expression in Oligodendrocytes Causes Glial and Neuronal DegenerationSemantic proximity Read ↗

Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human α-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System AtrophySemantic proximity Read ↗

Multiple System Atrophy: Pathology, Pathogenesis, and Path ForwardSemantic proximity Read ↗

An update on mammalian and non-mammalian animal models for biomarker development in neurodegenerative disordersSemantic proximity Read ↗

Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectivesSemantic proximity Read ↗

Neurological Phenotypes in Mouse Models of Mitochondrial Disease and Relevance to Human Neuropathology.Semantic proximity Read ↗

Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophySemantic proximity Read ↗

Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophySemantic proximity Read ↗

Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophySemantic proximity Read ↗

Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroadSemantic proximity Read ↗

Heterogeneity of Multiple System Atrophy: An UpdateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.